-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46

Benzinga·10/14/2026 18:16:28
Listen to the news
Citigroup analyst Yigal Nochomovitz initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $46.